Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jul:67:102540.
doi: 10.1016/j.amsu.2021.102540. Epub 2021 Jul 3.

Post-COVID-19 vaccine Guillain-Barré syndrome; first reported case from Qatar

Affiliations
Case Reports

Post-COVID-19 vaccine Guillain-Barré syndrome; first reported case from Qatar

Almurtada Razok et al. Ann Med Surg (Lond). 2021 Jul.

Abstract

Introduction: Guillain-Barré syndrome (GBS) is an immune-mediated peripheral neuropathy that was reported following meningococcus, polio, influenza and rabies vaccines. However, an association with the COVID-19 vaccine is yet to be established.

Presentation of case: We present the case of an elderly gentleman with no history of SARS-CoV-2 infection or any recent viral or bacterial illnesses who presented with GBS 20 days after the second dose of COVID-19 vaccination. The diagnosis was established based on physical examination, magnetic resonance imaging (MRI) of the spine, cerebrospinal fluid (CSF) analysis and electromyography (EMG).

Discussion: Due to the occurrence of GBS after certain types of infections, molecular mimicry has become widely acceptable as the underlying pathophysiology. The reported cases of GBS following vaccination further supported this theory, however proving a causal relationship between vaccines and GBS on the molecular level remains a challenge.

Conclusions: To the best of our knowledge this is the first reported case in the state of Qatar. It is important to mention that more research is needed to establish an association between COVID-19 vaccine and GBS. In our opinion, the benefits of COIVID-19 vaccine largely outweigh its risks.

Keywords: COVID-19 vaccine; Guillain-Barré syndrome; Molecular mimicry; Qatar.

PubMed Disclaimer

Conflict of interest statement

None to be declared.

Figures

Fig. 1
Fig. 1
Magnetic resonance image of the spine with intravenous gadolinium showing bilateral contrast enhancement of the nerve roots in the lumbar region and the upper part of the cauda equina (as indicated by the arrows).

References

    1. Agha Riaz A., Borrelli Mimi R., Farwana Reem, Koshy Kiron, Fowler Alexander J., Orgill Dennis P. For the SCARE Group. The SCARE 2018 statement: updating consensus Surgical CAse REport (SCARE) guidelines. Int. J. Surg. 2018;60:132–136. - PubMed
    1. Sejvar J.J., Baughman A.L., Wise M., Morgan O.W. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36(2):123–133. doi: 10.1159/000324710. Epub 2011 Mar 21. PMID: 21422765; PMCID: PMC5703046. - DOI - PMC - PubMed
    1. Willison H.J., Jacobs B.C., van Doorn P.A. Guillain-Barré syndrome. Lancet. 2016 Aug 13;388(10045):717–727. doi: 10.1016/S0140-6736(16)00339-1. Epub 2016 Mar 2. PMID: 26948435. - DOI - PubMed
    1. Kim J.H., Marks F., Clemens J.D. Looking beyond COVID-19 vaccine phase 3 trials. Nat. Med. 2021 Feb;27(2):205–211. doi: 10.1038/s41591-021-01230-y. Epub 2021 Jan 19. PMID: 33469205. - DOI - PubMed
    1. Polack F.P., Thomas S.J., Kitchin N., Absalon J., Gurtman A., Lockhart S., Perez J.L., Pérez Marc G., Moreira E.D., Zerbini C., Bailey R., Swanson K.A., Roychoudhury S., Koury K., Li P., Kalina W.V., Cooper D., Frenck R.W., Jr., Hammitt L.L., Türeci Ö., Nell H., Schaefer A., Ünal S., Tresnan D.B., Mather S., Dormitzer P.R., Şahin U., Jansen K.U., Gruber W.C. C4591001 clinical trial group. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N. Engl. J. Med. 2020 Dec 31;383(27):2603–2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10. PMID: 33301246; PMCID: PMC7745181. - DOI - PMC - PubMed

Publication types